Potential protective effects of Nigella sativaand allium sativum against fructose-induced metabolic syndrome in rats

Journal of Oleo Science

Volumn 63, Issue 8, 2014, Pages 839-848

  Al Rasheed, Nawal ^a   Al Rasheed, Nouf ^a   Bassiouni, Yieldez ^a   Faddah, Laila ^a   Mohamad, Azza M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Dyslipidemia; Garlic; Metabolic syndrome; Nigella sativa; Rats

Indexed keywords

BODY FLUIDS; CHOLESTEROL; LIPOPROTEINS; MEDICAL APPLICATIONS; METABOLISM; NUTRITION; PLANTS (BOTANY); RATING; RATS;

ANTI-OXIDANT ACTIVITIES; DYSLIPIDEMIAS; GARLIC; HIGH-DENSITY LIPOPROTEIN CHOLESTEROLS; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEINS; METABOLIC SYNDROMES; NIGELLA SATIVA;

FRUCTOSE;

CATALASE; CHOLESTEROL; FRUCTOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL; BLACK CUMIN; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED; DIET RESTRICTION; ENZYMOLOGY; GARLIC; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLIC SYNDROME X; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CATALASE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FASTING; FRUCTOSE; GARLIC; GLUCOSEPHOSPHATE DEHYDROGENASE; L-LACTATE DEHYDROGENASE; LIVER; MALE; METABOLIC SYNDROME X; NIGELLA SATIVA; ORGAN SIZE; RATS, WISTAR; TRIGLYCERIDES;

EID: 84905184929     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.ess14027     Document Type: Article

References (86)

1. Vega, G. L. Obesity, the metabolic syndrome, and cardiovascular disease. Am. Heart J. 142(6), 1108-1116 (2001).
2. Pitsavos, C.; Panagiotakos, D.; Weinem, M.; Stefanadis, C. Diet, Exercise and the metabolic syndrome. Rev. Diabet. Stud. 3(3), 118-126(2006).
3. Haffner, S. M.; Valdez, R. A.; Hazuda, H. P.; Mitchell, B. D.; Morales, P. A.; Stern, M. P. Prospective analysis of the insulin-resistance syndrome(Syndrome X). Diabetes 41(6), 715-722(1992).
4. Girman, C. J.; Rhodes, T., Mercuri, M.; Pyörälä, K.; Kjekshus, J.; Pedersen, T. R.; Beere, P. A.; Gotto, A. M.; Clearfield, M. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study(4S)and the Air Force/TexasCoronary Atherosclerosis Prevention StudyAFCAPS/TexCAPS). Am. J. Cardiol. 93(2), 136-141(2004).
5. Grundy, S. M.; Brewer, H. B.; Cleeman, J. I.; Smith, S. C.; Lenfant, D. Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438 (2004).
6. Grundy, S. M.; Cleeman, J. I.; Daniels, S. R.; Donato, K. A.; Eckel, R. H.; Franklin, B. A.; Gordon, D. J.; Krauss, R. M.; Savage, P. J.; Smith, S. C. Jr; Spertus, J. A.; Costa, F. "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific State ment". Circulation 112(17), 2735-2752(2005).
7. Ford, E. S.; Giles, W. H.; Mokdad, A. H. Increasing prevalence of the metabolic syndrome among US Adults. Diabetes Care 27(10), 2444-2449(2004).
8. Ford, E. S.; Li, C.; Zhao, G.; Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U. S. adolescents using the definition from the International Diabetes Federation. Diabetes Care 31(3), 587-589 (2008).
9. Al-Nozha, M.; Al-Khadra, A.; Arafah, M. R.; Al-Maatouq, M. A.; Khalil, M. Z.; Khan, N. B.; Al-Mazrou, Y. Y.; Al-Marzouki, K.; Al-Harthi, S. S.; Abdullah, M.; Al-Shahid, M. S.; Al-Mobeireek, A.; Nouh, M. S. Metabolic syndrome in Saudi Arabia. Saudi Med. J. 26(12), 1918-1925(2005).
10. Rodin, J. Effects of pure sugar versus mixed starch fructose loads on food intake. Appetite 17, 213-219 (1991).
11. Dolan, L. C.; Potter, S. M.; Burdock, G. A. Evidencebased review on the effect of normal dietary consumption of fructose on development of hyperlipidemia and obesity in healthy, normal weight individuals. Crit. Rev. Food Sci. Nutr. 50(1), 53-84(2010).
12. Nielsen, S. J.; Siega-Riz, A. M.; Popkin, B. M. Trends in energy intake in U. S. between 1977 and 1996: similar shifts seen across age groups. Obes. Res. 10, 370-378 (2002).
13. Devasagayam, T. P. A.; Tilak, J. C., Boloor, K. K.; Sane, K. S.; Ghaskadbi, S. S.; Lele, R. D. Free radicals and antioxidants in human health: Current Status and Future Prospects. JAPI 52, 794-804(2004).
14. Scalbert, A.; Manach, C.; Morand, C.; Remesy, C. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45, 287-306(2005).
15. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr. Rev. 70(5), 257-265(2012).
16. Lupidi, G.; Scire, A.; Camaioni, E.; Khalife, K. H.; De Sanctis, G.; Tanfani, F.; Damiani, E. Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin. Phytomedicine 17 (10), 714-720(2010).
17. Akhondian, J.; Kianifar, H.; Raoofziaee, M.; Moayedpour, A.; Toosi, M. B.; Khajedaluee, M. The effect of thymoquinone on intractable pediatric seizures(pilot study). Epilepsy Res. 93(1), 39-43(2011).
18. Chaieb, K.; Kouidhi, B.; Jrah, H.; Mahdouani, K.; Bakhrouf, A. Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complementary and Alternative Medicine 11, 29(2011).
19. Banerjee, S.; Parasramka, M.; Sarkar, F. H.; Mohammad, R. M. Molecular insight and preclinical perspective of thymoquinone as chemopreventiveagent and therapeutic adjunct in cancer. Nutrition, Diet and Cancer 83-107(2012).
20. Seki, T.; Hosono, T.; Hosono-Fukao, T.; Inada, K.; Tanaka, R.; Ogihara, J.; Ariga, T. Anticancer effects of diallyltrisulfide derived from garlic. Asia Pac. J. Clin. Nutr. 17(1), 249-252(2008).
21. Mohamed, E. F. Antiviral properties of garlic cloves juice compared with onion bulbs juice against potato virus Y(PVY). J. Am. Sci. 6(8), 302-310(2010).
22. Bachrach; G., Jamil, A.; Naor, R.; Tal, G.; Ludmer, Z.; Steinberg, D. Garlic allicin as a potential agent for controlling oral pathogens. J. Med. Food 14(11), 1338-1343(2011).
23. Banerjee, S. K.; Maulik, S. K. Effect of garlic on cardiovascular disorders: a review. Nutr. J. 1, 1-14(2002).
24. Rahman, K.; Lowe, G. M. Garlic and cardiovascular disease: A critical review. J. Nutr. 136(3), 736S-740S (2006).
25. Vazquez-Prieto, M. A.; González, R. E.; Renna, N. F.; Galmarini, C. R.; Miatello, R. M. Aqueous garlic extracts prevent oxidative stress and vascular remodeling in an experimental model of metabolic syndrome. J. Agric. Food Chem. 58(11), 6630-6635(2010).
26. Sánchez-Lozada, L. G.; Tapia, E.; Jiménez, A.; Bautista, P.; Cristóbal, M.; Nepomuceno, T.; Soto, V.; Ávila-Casado, C.; Nakagawa, T; Johnson, R. J.; Herrera-Acosta, J.; Franco, M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiology-Renal Physiol. 292(1), F423-F429(2007).
27. Hawsawi, Z. A.; Ali, B. A.; Bamosa, A. O. Effect of Nigella sativa(black seed)and thymoquinone on blood glucose in albino rats. Annals of Saudi Medicine 21 (3-4), 242-244(2001).
28. Padiya, R.; Khatua, T. N.; Bagul, P. K.; Kuncha, M.; Banerjee, S. K. Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats. Nutr. Metab. 8, 53(2011).
29. Ghezzi, A. C.; Cambri, L. T.; Botezelli, J. D.; Ribeiro, C; Dalia, R. A.; de Mello, M. A. Metabolic syndrome markers in wistar rats of different ages. Diabet. Metab. Syn. 4, 16(2012).
30. Friedewald, W. T.; Levy R. I.; Fredrickson, Ds. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502(1972).
31. Bergmeyer, H. U. Determination of Lactate dehydrogenase. J. Clin. Chem. Biochem. 13, 269(1975).
32. Bergmeyer, H. U.; Bernt, E.; Grassl, M.; Michel, G. Glucose-6-phosphate dehydrogenase. In UH Bergmeyer. Methods of Enzymatic Analysis, Verlag Chemie Weinheim, Academic Press, New York. 458-459(1974).
33. Aebi, H. Catalase in vitro. Methods Enzymol. 105, 121-126(1984).
34. Bray, G. A.; Nielsen, S. J.; Popkin, B. M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 79 (4), 537-543(2004).
35. Manuel-y-Keenoy, B.; Perez-Gallardo, L. Metabolic impact of the amount and type of dietary carbohydrates on the risk of obesity and diabetes. The Open Nutrition Journal 6, 21-34(2012).
36. Hallfrisch, J. Metabolic effects of dietary fructose. Faseb. J. 4, 2652-2660(1990).
37. Rayssiguier, Y.; Gueux, E.; Nowacki, W.; Rock, E.; Mazur, A. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes. Res. 19(4), 237-43(2006).
38. Nakagawa, T.; Hu, H.; Zharikov, S.; Tuttle, K. R.; Short, R. A.; Glushakova, O.; Ouyang, X.; Feig, D. I.; Block, E. R.; Herrera-Acosta, J.; Patel, J. M.; Johnson, R. J. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal Physiol. 290, F625-F631(2006).
39. Dai, S.; McNeill, J. H. Fructose-induced hypertension in rats is concentration-and duration-dependent. J. Pharmacol. Toxicol. Methods 33, 101-107(1995).
40. Hwang, I. S; Ho, H.; Hoffman, B. B.; Reaven, G. M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10, 512-516(1987).
41. Kasim-Karakas, S. E.; Vriend, H.; Almario, R.; Chow, L. C.; Goodman, M. N. Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. J. Lab. Clin. Med. 128, 208-213(1996).
42. Darwish, S. A.; Abdel-Azeim, T.; Noureldeen, N. M.; Abou Zeid, A.; Toussoun, N. Fructose-induced metabolic syndrome in rats, a role for Glitazones, fibrates and statins. Bull. Alex. Fac. Med. 42(4), 1182-1190 (2006).
43. Kim, H. Y.; Okubo, T.; Juneja, L. R.; Yokozawa, T. The protective role of amla(Emblica officinalis Gaertn) against fructose-induced metabolic syndrome in a rat model. Br. J. Nutr. 103(4), 502-512(2010).
44. Shahraki, M. R.; Harati, M.; Shahraki, A. R. Prevention of high fructose-induced metabolic syndrome in male Wistar rats by aqueous extract of Tamarindus Indica Seed. Acta Medica Iranica 49(5), 277-283(2011).
45. Rasineni, K.; Desireddy, S. Preventive effect of Catharanthusroseus (Linn.)against high-fructose diet-induced insulin resistance and oxidative stress in male Wistar rats J. Diabet. Mell. 1(30), 63-70(2011).
46. Tuovinen, C. G.; Bender, A. E. Some metabolic effects of prolonged feeding of starch, sucrose, fructose and carbohydrate-free diet in the rat. Nutr. Metab. 19(3-4), 161-72(1975).
47. Huanga, Y. J.; Fanga, V. S.; Juana, C. C.; Choua, Y. C.; Kwoka, C. F.; Hol, T. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 46(11), 1252-1258 (1997).
48. Brown, M. S; Goldstein, J. L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89(3), 331-340(1997).
49. Bennett, M. K.; Lopez, J. M.; Sanchez, H. B.; Osborne, T. F. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J. Biol. Chem. 270, 25578-25583(1995).
50. Postic, C.; Girard, j. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118(3), 829-838(2008).
51. Tappy, L.; Lê, K. A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 90 (1), 23-46(2010).
52. Herman, R. H.; Zakim, D.; Stifel, F. B. Effect of diet on lipid metabolism in experimental animals and man. Fed. Proc. 29, 1302-1307(1970).
53. Topping, D. L.; Mayes, P. A. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, and lipogenesis and carbohydrate metabolism. Biochem. J. 126, 295-311(1972).
54. Kazumi, T.; Odaka, H.; Hozumi, T.; Ishida, Y.; Amano, N.; Yoshino, G. Effects of dietary fructose or glucose on triglyceride production and lipogenic enzyme activities in the liver of Wistar fatty rats, an animal model of NIDDM. Endocr. J. 44, 239-245(1997).
55. Day, C. P.; James, O. F. Steatohepatitis: a tale of two "hits". Gastroenterology 114, 842-845(1998).
56. Bahgat, N. M.; Soliman, G. Z. A. Effect of Nigella sativa supplementation in diet on metabolic syndrome in aged Rats. J. Am. Sci. 7(7), 577-83(2011).
57. Benhaddou-Andaloussi, A.; Martineau, L.; Vuong, T.; Meddah, B.; Madiraju, P.; Settaf, A.; Haddad, P. S. The in vivo antidiabetic activity of Nigella sativa is mediated through activation of the AMPK Pathway and increased muscle Glut4 content. Evidence-Based Complementary and Alternative Medicine 1-9(2011).
58. Parhizkar, S.; Latiff, L. A.; Rahman, S. A.; Dollah, M, A. Preventive effect of Nigella sativa on metabolic syndrome in menopause induced rats. J. Med. Plants Res. 5, 1478-1484(2011).
59. Parhizkar, S.; Latiff, L. A.; Rahman, S. A.; Hanachi, P.; Dollah, M. A. Metabolic impact of Nigella sativa extracts on experimental menopause induced rats. J. Appl. Pharm. Sci. 1(9), 38-42(2011).
60. Najmi, A.; Naseeruddin, M.; Khan, R. A.; Shahzad, F. Therapeutic effect of Nigella sativa in patients of poor glycemic control. Asian J. Pharm. Clin. Res. 5(3), 224-228(2012).
61. Kaatabi, H.; Bamosa, A. O.; Lebda, F. M.; Al Elq, A. H.; Al-Sultan, A. I. Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients. J. Family Comm. Med. 19(3), 155-161(2012).
62. Tasawar, Z.; Siraj, Z.; Ahmad, N.; Lashari, M. H. The Effects of Nigella sativa(Kalonji)on lipid profile in patients with stable coronary artery disease in Multan, Pakistan. Pak. J. Nutr. 10(2), 162-167(2011).
63. Najmi, A.; Haque, S. F.; Naseeruddin, M.; Khan, R. A. Effect of Nigella Sativa oil on various clinical and biochemical parameters of metabolic syndrome. Int. J. Diabet. Metab. 16, 85-87(2008).
64. Bamosa, A. O.; Ali, B. A.; Sowayan, S. A. Effect of oral ingestion of Nigella sativa seeds on some blood parameters. Saudi Pharm. J. 5, 126-129(1997).
65. Bamosa, A. O.; Ali, B. A.; al-Hawsawi, Z. A. The effect of thymoquinone on blood lipids in rats. Ind. J. Physiol. Pharmacol. 46, 195-201(2002).
66. Al-Naqeep, G.; Ismail, M.; Allaudin, Z. Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by thymoquinone-rich fraction and thymoquinone in Hep G2 cells. J. Nutrigenet. Nutrigen. 2(4-5), 163-72(2009).
67. Vazquez-Prieto, M. A.; González, R. E.; Renna, N. F.; Galmarini, C. R.; Miatello, R. M. Aqueous garlic extracts prevent oxidative stress and vascular remodeling in an experimental model of metabolic syndrome. J. Agric. Food Chem. 58(11), 6630-6635(2010).
68. Durak, I.; Kavutcu, M.; Aytaç, B.; Avci, A.; Devrim, E.; Ozbek, H.; Oztürk, H. S. Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. J. Nutr. Biochem. 15(6), 373-7(2004).
69. Bordia, A.; Verma, S. K.; Srivastava, K. C. Effect of garlic (Allium sativum)on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 58(4), 257-63(1998).
70. Ashraf, R.; Khan, R. A.; Ashraf, I. Garlic(Allium sativum)supplementation with standard antidiabetic agent provides better diabetic control in type 2 Diabetic patients. Pak. J. Pharm. Sci. 24(4), 565-570 (2011).
71. Maiti, R.; Jana, D.; Das, U. K.; Ghosh, D. Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 92, 85-91(2004).
72. Klover, P. J.; Mooney, R. A. Hepatocytes: critical for glucose homeostasis. Int. J. Biochem. Cell Biol. 36, 753-8(2004).
73. Zhang, Z.; Apse, K.; Pang, J.; Stanton, R. C. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J. Biol. Chem. 275, 40042-40047(2000).
74. Rajasekar, P.; Kaviarasam, S.; Anuradha, C. V. L-carnitine administration prevents oxidative stress in high fructose-fed insulin resistant rats. Diabetologia Croatica 34, 21-28(2005).
75. Polizio, A. H.; Gonzales, S.; Muñoz, M. C.; Peña, C.; Tomaro, M. L. Behaviour of the antioxidant defense system and heme oxygenase-1 protein expression in fructose-hypertensive rats. Clin. Exp. Pharmacol. Physiol. 33(8), 734-739(2006).
76. Busserolles, J.; Gueux, E.; Rock, E.; Mazur, A.; Rayssiguier, Y. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and pro-oxidative effects of fructose. J. Nutr. 132(11), 3379-3382(2002).
77. Flores, M. D.; Hernández, M. A. I.; Galván, R. E.; Gutiérrez, M.; Reyes, G. D.; Navarro, R. M.; Lira, D. P.; Camarillo, C. O.; Rojas, C. V.; Cruz, M.; Gutman, L. A. B. Glucose-6-phosphate dehydrogenase activity and NADPH/NADP-ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat. Life Sci. 78, 2601-2607(2006).
78. Jana, K.; Chatterjee, K.; Ali, K. M.; De, D.; Bera, T. K.; Ghosh, D. Antihyper-glycemic and antioxidative effects of the hydro-methanolic extract of the seeds of Caesalpinia bonduc on streptozotocin-induced diabetes in male albino rats. Pharmacognosy Res. 4(1), 57-62(2012).
79. Mohamed, A. M.; El-Sharkawy, F., Ahmed, S. A.; Magdi, A. S.; Badary, O. A. (2009)Glycemic control and therapeutic effect of Nigella sativa and Curcuma longa on rats with streptozotocin-induced diabetic hepatopathy. J. Pharmacol. Toxicol. 4(2), 45-57(2009).
80. Pari, L.; Sankaranarayanan, C. Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 85, 830-834(2009).
81. Heinle, H.; Betz, E. Effects of dietary garlic supplementation in a rat model of atherosclerosis. Arzneimittelforschung 44(5), 614-617(1994).
82. Flora, S. J.; Mehta, A.; Gupta, R. Prevention of arsenicinduced hepatic apoptosis by concomitant administration of garlic extracts in mice. Chem. Biol. Interact. 177(3), 227-233(2009).
83. Dollah, M. A; Parhizkar, S.; Abdul Latiff, L.; Bin Hassan, M. H. Toxicity effect of Nigella Sativa on the liver function of rats. Adv. Pharm. Bull. 3(1), 97-102 (2013).
84. Gani, A. S.; John, S. A. Evaluation of hepatoprotective effect of Nigella Sativa L. Int. J. Pharm. Pharm. Sci. 5(4), 428-430(2013).
85. Banerjee, S. K.; Maulik, M.; Manchanda, S. C.; Dinda, A. K.; Das, T. K.; Maulik, S. K. Garlic-induced alteration in rat liver and kidney morphology and associated changes in endogenous antioxidant status. Food Chem. Toxicol. 39(8), 793-7(2001).
86. Samson, E. S.; Olasunkanmi, A. K.; Joel, J. S.; Alfred, E. F. Haematological and Hepatotoxic Potential of Onion (Allium cepa)and Garlic(Allium sativum)Extracts in Rats. Eur. J. Med. Plants 2(4), 290-307(2012).